There are several ethical considerations when it comes to the use of non-specific immunostimulants in toxicology. The potential for misuse and the need for informed consent are critical issues. Patients and consumers must be adequately informed about the benefits and risks associated with these agents. Additionally, there is a need for transparency in the research and development process to ensure that the data supporting their use is robust and unbiased.
